entertainment -WSS

entertainment

author：comprehensive 2025-10-01 12:34:25 - browse：7548

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Health insurers say they are turning to AI to cut costs, improve care

hotspot

WSS

PhRMA sues HHS over Medicare drug price negotiation

Community addresses injustice for Long Island mothers

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Community addresses injustice for Long Island mothers

Health insurers say they are turning to AI to cut costs, improve care

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

hotspot

entertainment

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Do more moles mean more problems? Not so, says new study

Tori Bowie and the unacceptable rates of Black maternal death

Make 'food is medicine' a key part of White House nutrition meeting

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Medicare details structure of new drug price negotiation program

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

After affirmative action ruling, medical educators look to 'holistic review'

Report: NIH

focus

New case study details death in closely watched Alzhiemer's trial

What will save rural psychiatry services? Higher Medicaid payments

A new study asks: Are we harming blood donors by taking blood?

Australia's humpback populations rebound raising hopes of marine scientists

Make 'food is medicine' a key part of White House nutrition meeting

Listen: PBM conflicts, RSV vaccines, & the future of flu season

hotspot

explore

hotspot

focus